Pharmaceuticals

Global Anti-Asthmatic and COPD Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends

October 25, 2021 by The Business Research Company

The Global Anti-Asthmatic and COPD Drugs Market Report by The Business Research Company covers anti-asthmatic and COPD drugs market drivers and restraints, anti-asthmatic and COPD drugs market size, major players, and the impact of COVID-19 on the anti-asthmatic and COPD drugs market.

The anti-asthmatics and COPD drugs market consists of sales of anti-asthmatics and COPD drugs by entities (organizations, sole traders and partnerships) that manufacture anti-asthmatics and COPD drugs which are used to prevent and treat asthma and chronic obstructive pulmonary disease (COPD). The anti-asthmatics and COPD drug industry includes establishments that manufacture anti-asthmatics and COPD drugs such as bronchodilators, anti-inflammatory drugs, monoclonal antibodies and combination drugs.

The global anti-asthmatics and COPD drugs market reached a value of nearly $75,376.4 million in 2020, having increased at a compound annual growth rate (CAGR) of 12.7% since 2015. The market is expected to grow from $75,376.4 million in 2020 to $86,436.2 million in 2025 at a rate of 2.8%. The anti-asthmatics and COPD drugs market is then expected to grow at a CAGR of 5.8% from 2025 and reach $114,413.5 million in 2030.

E-cigarette, a substitute of direct tobacco smoking is gaining popularity. E-cigarette smoking/ vaping incurs risk of developing asthma among individuals as it contains nicotine extracts from tobacco. E-cigarettes which are also known as e-cigs, vaporizer cigarettes, and vape pens are electronic battery-operated devices that emit doses of vaporized nicotine, or non-nicotine solutions to provide a similar sensation of inhaling tobacco to the user. The usage of e-cigs has been increasing. For instance, in the USA, as of 2020, 19.6% of high school students and 4.7% of middle school students were reported using an e-cigarette. The number of users of e-cigarettes is expected to increase further. Rising adoption of e-cigs will increase the number of asthma patients in the forecast period, which in turn is expected to drive the anti-asthmatics and COPD drugs market during this period.

Request A Sample For The Global Anti-Asthmatic and COPD Drugs Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2417&type=smp

Some anti-asthmatic and COPD drugs market trends include use of probiotics to treat asthma. Probiotics can enhance the host immune system through the gut ecosystem and could be beneficial for the treatment of allergic diseases such as asthma. Moreover, companies in the anti-asthmatics and COPD drugs market are increasingly developing bioelectric medicines for the treatment of asthma patients. Bioelectronic Medicine focuses on electrical signaling in the nervous system to tackle a wide range of chronic diseases using miniaturized, implantable devices that can modify electrical signals that pass along nerves in the body, including irregular or altered impulses that occur in many illnesses.

Global anti-asthmatic and COPD drugs market segments include:

1) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-inflammatory Drugs, Combination Drugs

2) By End User: Asthma Patients, COPD Patients

3) By Distribution Channel: General Pharmacies, Hospital Pharmacies, Online Retailers

4) By Therapy: Preventive, Curative

5) By Route of Administration: Oral, Inhaled, Intravenous, Subcutaneous

6) By Age Group: Below 5, 5-14, 15-60, Above 60

7) By Prescription: Prescription, Over The Counter (OTC)

8) By Drug Type: Branded, Generic

9) By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Anti-Asthmatic and COPD Drugs Opportunities And Strategies: Forecast To 2030:

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

The Anti-Asthmatic and COPD Drugs Opportunities And Strategies: Forecast To 2030 is one of a series of new reports from The Business Research Company that provides anti-asthmatic and COPD drugs market overviews, analyzes and forecasts market size, share, anti-asthmatic and COPD drugs market players, anti-asthmatic and COPD drugs market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.

The anti-asthmatic and COPD drugs identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More:

Read Anti-Asthmatic and COPD Drugs Opportunities And Strategies: Forecast To 2030 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Market Players Covered: GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Novartis AG

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Anti-Asthmatic and COPD Drugs Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.

Opportunities For Companies In The Anti-Asthmatic and COPD Drugs Sector: The report reveals where the global industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at www.thebusinessresearchcompany.com

Here is a list of reports from The Business Research Company similar to the Anti-Asthmatic and COPD Drugs Opportunities And Strategies: Forecast To 2030:

Nebulizers Global Market Report 2021

Respiratory Devices And Equipment (Therapeutic) Global Market Report 2021

Respiratory Devices And Equipment (Diagnostic) Global Market Report 2021

Reach us at:

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info